Der var ingen forskel på typen af hændelser behandlingsgrupperne imellem, uanset om patienterne var over eller under 80 år ved inklusion.
There were no differences in the nature of adverse events between treatment groups regardless of whether patients were aged below or above 80 at inclusion.